• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Pfizer begins plan to challenge Shingrix with an mRNA vaccine

cafead

Administrator
Staff member
  • cafead   Feb 12, 2023 at 07:52: PM
via The two companies believe a shot based on messenger RNA technology can be more tolerable and efficiently produced than GSK’s vaccine.

article source